CHD7 Mutations in Patients Initially Diagnosed with Kallmann Syndrome--the Clinical Overlap with CHARGE Syndrome

Overview

Journal Clin Genet

Specialty Genetics

Date 2008 Nov 22

PMID 19021638

Citations 88

Authors

M C J Jongmans

C M A van Ravenswaaij-Arts

N Pitteloud

T Ogata

N Sato

H L Claahsen-van der Grinten

K van der Donk

S Seminara

J E H Bergman

H G Brunner

W F Crowley Jr

L H Hoefsloot

Affiliations

Soon will be listed here.

Abstract

Kallmann syndrome (KS) is the combination of hypogonadotropic hypogonadism and anosmia or hyposmia, two features that are also frequently present in CHARGE syndrome. CHARGE syndrome is caused by mutations in the CHD7 gene. We performed analysis of CHD7 in 36 patients with KS and 20 patients with normosmic idiopathic hypogonadotropic hypogonadism (nIHH) in whom mutations in KAL1, FGFR1, PROK2 and PROKR2 genes were excluded. Three of 56 KS/nIHH patients had de novo mutations in CHD7. In retrospect, these three CHD7-positive patients showed additional features that are seen in CHARGE syndrome. CHD7 mutations can be present in KS patients who have additional features that are part of the CHARGE syndrome phenotype. We did not find mutations in patients with isolated KS. These findings imply that patients diagnosed with hypogonadotropic hypogonadism and anosmia should be screened for clinical features consistent with CHARGE syndrome. If such features are present, particularly deafness, dysmorphic ears and/or hypoplasia or aplasia of the semicircular canals, CHD7 sequencing is recommended.

Citing Articles

Disorders of puberty and neurodevelopment: A shared etiology?.

Read J, Vasile-Tudorache A, Newsome A, Lorente M, Agustin-Pavon C, Howard S Ann N Y Acad Sci. 2024; 1541(1):83-99.

PMID: 39431640 PMC: 11580780. DOI: 10.1111/nyas.15246.

Kismet/CHD7/CHD8 and Amyloid Precursor Protein-like Regulate Synaptic Levels of Rab11 at the Neuromuscular Junction.

Hendricks E, Linskey N, Smith I, Liebl F Int J Mol Sci. 2024; 25(15).

PMID: 39125997 PMC: 11313043. DOI: 10.3390/ijms25158429.

Diagnosis challenges in CHARGE syndrome: A novel variant and clinical description.

Saenz Hinojosa S, Reyes C, Romero V Heliyon. 2024; 10(6):e28024.

PMID: 38545186 PMC: 10965510. DOI: 10.1016/j.heliyon.2024.e28024.

Digenic and inheritance Unveils phenotypic variability in a family mainly presenting with hypogonadotropic hypogonadism.

Wang T, Ren W, Fu F, Wang H, Li Y, Duan J Heliyon. 2023; 10(1):e23272.

PMID: 38148819 PMC: 10750161. DOI: 10.1016/j.heliyon.2023.e23272.

CHD7 variants associated with hearing loss and enlargement of the vestibular aqueduct.

Roux I, Fenollar-Ferrer C, Lee H, Chattaraj P, Lopez I, Han K Hum Genet. 2023; 142(10):1499-1517.

PMID: 37668839 PMC: 10511616. DOI: 10.1007/s00439-023-02581-x.

References

Abadie V, Wiener-Vacher S, Morisseau-Durand M, Poree C, Amiel J, Amanou L . Vestibular anomalies in CHARGE syndrome: investigations on and consequences for postural development. Eur J Pediatr. 2000; 159(8):569-74. DOI: 10.1007/s004319900409. View

Sanlaville D, Verloes A . CHARGE syndrome: an update. Eur J Hum Genet. 2007; 15(4):389-99. DOI: 10.1038/sj.ejhg.5201778. View

Pitteloud N, Meysing A, Quinton R, Acierno Jr J, Dwyer A, Plummer L . Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol. 2006; 254-255:60-9. DOI: 10.1016/j.mce.2006.04.021. View

Chalouhi C, Faulcon P, Le Bihan C, Hertz-Pannier L, Bonfils P, Abadie V . Olfactory evaluation in children: application to the CHARGE syndrome. Pediatrics. 2005; 116(1):e81-8. DOI: 10.1542/peds.2004-1970. View

Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J . CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab. 2005; 90(10):5621-6. DOI: 10.1210/jc.2004-2474. View

Pitteloud N, Zhang C, Pignatelli D, Li J, Raivio T, Cole L . Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2007; 104(44):17447-52. PMC: 2077276. DOI: 10.1073/pnas.0707173104. View

Legouis R, Hardelin J, Levilliers J, Claverie J, Compain S, Wunderle V . The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell. 1991; 67(2):423-35. DOI: 10.1016/0092-8674(91)90193-3. View

Dode C, Levilliers J, Dupont J, De Paepe A, Le Du N, Soussi-Yanicostas N . Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003; 33(4):463-5. DOI: 10.1038/ng1122. View

Jongmans M, Admiraal R, van der Donk K, Vissers L, Baas A, Kapusta L . CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2005; 43(4):306-14. PMC: 2563221. DOI: 10.1136/jmg.2005.036061. View

10.

Sato N, Katsumata N, Kagami M, Hasegawa T, Hori N, Kawakita S . Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab. 2004; 89(3):1079-88. DOI: 10.1210/jc.2003-030476. View

11.

Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R . A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature. 1991; 353(6344):529-36. DOI: 10.1038/353529a0. View

12.

Jongmans M, Hoefsloot L, van der Donk K, Admiraal R, Magee A, van de Laar I . Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. Am J Med Genet A. 2007; 146A(1):43-50. DOI: 10.1002/ajmg.a.31921. View

13.

Kim S, Hu Y, Cadman S, Bouloux P . Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome. J Neuroendocrinol. 2007; 20(2):141-63. DOI: 10.1111/j.1365-2826.2007.01627.x. View

14.

Vissers L, van Ravenswaaij C, Admiraal R, Hurst J, de Vries B, Janssen I . Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004; 36(9):955-7. DOI: 10.1038/ng1407. View

15.

Oliveira L, Seminara S, Beranova M, Hayes F, Valkenburgh S, Schipani E . The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab. 2001; 86(4):1532-8. DOI: 10.1210/jcem.86.4.7420. View

16.

Dode C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler M . Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006; 2(10):e175. PMC: 1617130. DOI: 10.1371/journal.pgen.0020175. View

17.

Higgs D, Vernimmen D, Hughes J, Gibbons R . Using genomics to study how chromatin influences gene expression. Annu Rev Genomics Hum Genet. 2007; 8:299-325. DOI: 10.1146/annurev.genom.8.080706.092323. View

18.

Ogata T, Fujiwara I, Ogawa E, Sato N, Udaka T, Kosaki K . Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation. Endocr J. 2006; 53(6):741-3. DOI: 10.1507/endocrj.k06-099. View

19.

Bergman J, de Wijs I, Jongmans M, Admiraal R, Hoefsloot L, van Ravenswaaij-Arts C . Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome. Eur J Med Genet. 2008; 51(5):417-25. DOI: 10.1016/j.ejmg.2008.03.003. View

20.

Lalani S, Safiullah A, Fernbach S, Harutyunyan K, Thaller C, Peterson L . Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet. 2006; 78(2):303-14. PMC: 1380237. DOI: 10.1086/500273. View